DK458679A - Fremgangsmaade til fremstilling af nitrogenholdige heterocycliske forbindelser - Google Patents

Fremgangsmaade til fremstilling af nitrogenholdige heterocycliske forbindelser

Info

Publication number
DK458679A
DK458679A DK458679A DK458679A DK458679A DK 458679 A DK458679 A DK 458679A DK 458679 A DK458679 A DK 458679A DK 458679 A DK458679 A DK 458679A DK 458679 A DK458679 A DK 458679A
Authority
DK
Denmark
Prior art keywords
procedure
containing heterocyclic
heterocyclic compounds
nitrogen containing
preparing nitrogen
Prior art date
Application number
DK458679A
Other languages
English (en)
Inventor
D Cox
H Cairns
N Chadwick
J L Suschitzky
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fisons Ltd filed Critical Fisons Ltd
Publication of DK458679A publication Critical patent/DK458679A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/86Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88Oxygen atoms
    • C07D239/90Oxygen atoms with acyclic radicals attached in position 2 or 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/24Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D335/00Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/06Benzothiopyrans; Hydrogenated benzothiopyrans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK458679A 1978-10-31 1979-10-30 Fremgangsmaade til fremstilling af nitrogenholdige heterocycliske forbindelser DK458679A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7842679 1978-10-31
GB7920760 1979-06-14

Publications (1)

Publication Number Publication Date
DK458679A true DK458679A (da) 1980-05-01

Family

ID=26269406

Family Applications (1)

Application Number Title Priority Date Filing Date
DK458679A DK458679A (da) 1978-10-31 1979-10-30 Fremgangsmaade til fremstilling af nitrogenholdige heterocycliske forbindelser

Country Status (32)

Country Link
US (1) US4419352A (da)
AR (1) AR230449A1 (da)
AT (1) AT379811B (da)
AU (1) AU528648B2 (da)
BR (1) BR7907006A (da)
CA (1) CA1142520A (da)
CH (1) CH643264A5 (da)
CS (1) CS231166B2 (da)
CU (1) CU21123A (da)
DD (1) DD146954A5 (da)
DE (1) DE2943658A1 (da)
DK (1) DK458679A (da)
FI (1) FI67702C (da)
FR (1) FR2440371A1 (da)
GR (1) GR73861B (da)
HK (1) HK66185A (da)
HU (1) HU183087B (da)
IE (1) IE49464B1 (da)
IL (1) IL58579A (da)
KE (1) KE3540A (da)
LU (1) LU81841A1 (da)
MA (1) MA18631A1 (da)
MY (1) MY8500439A (da)
NL (1) NL7907916A (da)
NO (1) NO154522C (da)
NZ (1) NZ191956A (da)
PH (1) PH15442A (da)
PL (1) PL130691B1 (da)
PT (1) PT70392A (da)
SE (1) SE451071B (da)
SG (1) SG40885G (da)
SU (1) SU1014476A3 (da)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260306A (en) * 1981-07-24 1993-11-09 Fisons Plc Inhalation pharmaceuticals
GB8402047D0 (en) * 1984-01-26 1984-02-29 Fisons Plc Nitrogen heterocycles
EP0162556B1 (en) * 1984-04-13 1991-11-06 FISONS plc Novels forms and formulations of nedocromil sodium
GB8501015D0 (en) * 1985-01-16 1985-02-20 Riker Laboratories Inc Drug
GB8607159D0 (en) * 1986-03-22 1986-04-30 Smith & Nephew Ass Pharmaceutical composition
NL8701335A (nl) * 1986-06-21 1988-01-18 Sandoz Ag Orale farmaceutische preparaten.
EP0279121B1 (en) * 1986-12-23 1993-09-01 FISONS plc Pharmaceutical compositions comprising an aqueous solution of a pyranoquinoline derivative
USRE38628E1 (en) * 1986-12-23 2004-10-19 Fisons Plc Pharmaceutical compositions
USH672H (en) 1986-12-31 1989-09-05 E. R. Squibb & Sons, Inc. Stable antifungal capsule formulation
US4767612A (en) * 1987-01-23 1988-08-30 Rorer Pharmaceutical Corporation Triamcinolone acetonide for the treatment of allergic rhinitis
GB8704089D0 (en) * 1987-02-21 1987-03-25 Fisons Plc Method of treatment
GB2202145B (en) * 1987-03-17 1991-01-02 Fisons Plc Compositions of nedocromil for dermatological use.
US5648084A (en) * 1990-02-28 1997-07-15 Guttag; Alvin Multiple dosage medicine drop bottle
AU650036B2 (en) * 1990-07-25 1994-06-09 Teijin Limited Benzopyran derivative, production thereof, and pharmaceutical composition containing the same
US5294433A (en) * 1992-04-15 1994-03-15 The Procter & Gamble Company Use of H-2 antagonists for treatment of gingivitis
US5453431A (en) * 1993-10-29 1995-09-26 Gilman; Andrew L. Use of hydroxychloroquine for treatment of graft-versus-host disease
ZA966579B (en) * 1995-08-04 1998-02-02 Wakamoto Pharma Co Ltd O/W emulsion composition for eye drops.
US5891472A (en) * 1996-11-19 1999-04-06 Meri Charmyne Russell Treatment of equine laminitis
US5989571A (en) * 1997-07-23 1999-11-23 Millenium Pharmaceutical Technologies, Inc. Contact dermatitis pharmaceutical preparation with anti-histamine and anti-inflammatory
US5885550A (en) * 1998-07-02 1999-03-23 Vallier; Deandra K. Ophthalmic whitening solution
US7101547B1 (en) 1999-01-22 2006-09-05 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Method for the prevention and treatment of diseases caused by an inflammatory response mediated by endogenous substance P by using anti-substance P antibodies
AU2001264616A1 (en) * 2000-05-17 2001-11-26 Cor Therapeutics, Inc. Methods for producing amino substituted chromanes and intermediates therefor
US9132116B2 (en) * 2004-08-02 2015-09-15 Willowcroft Pharm Inc. Mast cell stabilizers to prevent or treat laminitis
GB0524808D0 (en) * 2005-12-05 2006-01-11 Novartis Ag Organic compounds
DE102007028095A1 (de) * 2007-06-19 2009-01-15 Bachmann, Vincent Zubereitung zur Behandlung von Hufrehe bei Equiden
FR2924344B1 (fr) * 2007-12-04 2010-04-16 Pf Medicament Utilisation de la mequitazine sous la forme de racemate ou d'enantiomeres pour la preparation d'un medicament destine au traitement ou a la prevention de pathologies impliquant les recepteurs histaminiques h4.
EP2424527B8 (en) * 2009-04-29 2019-07-17 Willowcraft Pharm Inc. Mast cell stabilizers to prevent or treat laminitis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1504709A (en) * 1974-12-07 1978-03-22 Fisons Ltd N-substituted quinolinone-2-carboxyl. acid der
AU513456B2 (en) * 1977-03-08 1980-12-04 Takeda Chemical Industries Ltd. l-Azaxanthone-3-carboxylic acids
IL54614A (en) * 1977-05-04 1983-07-31 Fisons Ltd Dihydrodioxo-pyranoquinoline dicarboxylic acid derivatives,their production and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
CS735979A2 (en) 1984-02-13
PL130691B1 (en) 1984-08-31
HK66185A (en) 1985-09-13
AU5228779A (en) 1980-05-08
FI67702B (fi) 1985-01-31
AU528648B2 (en) 1983-05-05
US4419352A (en) 1983-12-06
LU81841A1 (fr) 1980-05-07
DD146954A5 (de) 1981-03-11
SU1014476A3 (ru) 1983-04-23
NZ191956A (en) 1984-05-31
NL7907916A (nl) 1980-05-02
IL58579A0 (en) 1980-01-31
AR230449A1 (es) 1984-04-30
GR73861B (da) 1984-05-08
SG40885G (en) 1986-05-02
AT379811B (de) 1986-03-10
PL219304A1 (da) 1980-12-01
PT70392A (en) 1979-11-01
NO154522B (no) 1986-06-30
CH643264A5 (fr) 1984-05-30
KE3540A (en) 1985-07-12
FR2440371A1 (fr) 1980-05-30
DE2943658A1 (de) 1980-05-14
PH15442A (en) 1983-01-18
DE2943658C2 (da) 1991-08-01
SE7908995L (sv) 1980-05-01
CS231166B2 (en) 1984-10-15
FI67702C (fi) 1985-05-10
NO793469L (no) 1980-05-02
CA1142520A (en) 1983-03-08
HU183087B (en) 1984-04-28
IE792074L (en) 1980-04-30
CU21123A (es) 1982-08-28
IL58579A (en) 1985-12-31
NO154522C (no) 1986-10-08
FI793369A (fi) 1980-05-01
MY8500439A (en) 1985-12-31
ATA701479A (de) 1985-07-15
IE49464B1 (en) 1985-10-16
FR2440371B1 (da) 1983-01-28
MA18631A1 (fr) 1980-07-01
SE451071B (sv) 1987-08-31
BR7907006A (pt) 1980-07-15

Similar Documents

Publication Publication Date Title
DK425579A (da) Fremgangsmaade til fremstilling af heterocycliske forbindelser
DK458679A (da) Fremgangsmaade til fremstilling af nitrogenholdige heterocycliske forbindelser
DK363179A (da) Fremgangsmaade til fremstilling af tetrazolylalkoxycarbostyrilderivater
DK457779A (da) Fremgangsmaade til fremstilling af 4-hydroxy-2-pyronderivater
DK357181A (da) R fremgangsmaade til fremstilling af heterocycliske forbindelse
DK188683A (da) Fremgangsmaade til fremstilling af heterocycliske forbindelser
DK43279A (da) Fremgangsmaade til fremstilling af 2-penem-3-carboxylsyreforbindelser
DK488379A (da) Fremgangsmaade til fremstilling af polyetherderivater
DK357081A (da) Fremgangsmaade til fremstilling af heterocycliske forbindelser
DK357281A (da) R fremgangsmaade til fremstilling af heterocycliske forbindelse
DK517776A (da) Fremgangsmade til femstilling af heterocycliske forbindelser
DK145698C (da) Analogifremgangsmaade til fremstilling af 2-alkoxyadeninderivater
DK388079A (da) R fremgangsmaade til fremstilling af heterocycliske forbindelse
DK446980A (da) R fremgangsmaade til fremstilling af heterocycliske forbindelse
DK138879A (da) Fremgangsmaade til fremstilling af lysergolderivater
DK216979A (da) Fremgangsmaade til fremstilling af tricykliske ortokondenserede heterocykliske forbindelser
DK147145C (da) Analogifremgangsmaade til fremstilling af chlorambucilderivater
DK89480A (da) R fremgangsmaade til fremstilling af heterocycliske forbindelse
DK90681A (da) R fremgangsmaade til fremstilling af heterocycliske forbindelse
DK420480A (da) R fremgangsmaade til fremstilling af heterocycliske forbindelse
DK38577A (da) Fremgangsmade til fremstilling af betalactamholdige forbindelser
DK355180A (da) Fremgangsmaade til fremstilling af heterocycliske forbindelser
DK344180A (da) R fremgangsmaade til fremstilling af heterocycliske forbindelse
DK381581A (da) Fremgangsmaade til fremstilling af heterocycliske derivater
DK247877A (da) Fremgangsmade til fremstilling af klavamforbindelser

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment